Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP384593.RACw8r9UtcAbjhvz8bw6i8XyL5HUwv1aEg1xOTcgXqhpw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP384593.RACw8r9UtcAbjhvz8bw6i8XyL5HUwv1aEg1xOTcgXqhpw130_assertion type Assertion NP384593.RACw8r9UtcAbjhvz8bw6i8XyL5HUwv1aEg1xOTcgXqhpw130_head.
- NP384593.RACw8r9UtcAbjhvz8bw6i8XyL5HUwv1aEg1xOTcgXqhpw130_assertion description "[COX-2 has also been strongly implicated in urinary bladder cancer primarily by studies with nonselective COX- and COX-2-selective inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384593.RACw8r9UtcAbjhvz8bw6i8XyL5HUwv1aEg1xOTcgXqhpw130_provenance.
- NP384593.RACw8r9UtcAbjhvz8bw6i8XyL5HUwv1aEg1xOTcgXqhpw130_assertion evidence source_evidence_literature NP384593.RACw8r9UtcAbjhvz8bw6i8XyL5HUwv1aEg1xOTcgXqhpw130_provenance.
- NP384593.RACw8r9UtcAbjhvz8bw6i8XyL5HUwv1aEg1xOTcgXqhpw130_assertion SIO_000772 15753378 NP384593.RACw8r9UtcAbjhvz8bw6i8XyL5HUwv1aEg1xOTcgXqhpw130_provenance.
- NP384593.RACw8r9UtcAbjhvz8bw6i8XyL5HUwv1aEg1xOTcgXqhpw130_assertion wasDerivedFrom befree-20140225 NP384593.RACw8r9UtcAbjhvz8bw6i8XyL5HUwv1aEg1xOTcgXqhpw130_provenance.
- NP384593.RACw8r9UtcAbjhvz8bw6i8XyL5HUwv1aEg1xOTcgXqhpw130_assertion wasGeneratedBy ECO_0000203 NP384593.RACw8r9UtcAbjhvz8bw6i8XyL5HUwv1aEg1xOTcgXqhpw130_provenance.